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Preoperative management 
of hypoplastic left heart 
syndrome
ABSTRACT
Pediatricians are frequently involved in the care of cyanotic newborns in the labor and delivery room, as well as in the well 
baby nursery. Causes of hypoxia and cyanosis in the term newborn can be found within all physiological systems. Congenital 
heart structural diseases account for the largest diagnostic category. There have been significant advances during the past 
years in the diagnosis and treatment of neonates with critical congenital heart disease, especially in the field of pre- and 
post-operative intensive care. 
The term hypoplastic left heart syndrome (HLHS) describes a spectrum of cardiac structural abnormalities characterized by 
marked hypoplasia of the left ventricle and ascending aorta. Prenatal diagnosis, initial resuscitation and optimal preoperative 
management are key elements that allow the best opportunity for low mortality and normal neurodevelopment in affected 
newborns.  Preoperatively, the goal is to achieve adequate systemic oxygen delivery. Patency of the ductus arteriosus (DA) 
is critical for survival until surgery. Blood flow to the pulmonary and systemic circulations should be nearly balanced (goal 
Qp/Qs ratio of 1).  The immediate
 therapy for all infants with HLHS is an intravenous infusion of prostaglandin E1 (PGE1) in 
order to manipulate the DA and maintain ductal patency. Oxygen saturations of 75% to 85% by pulse oximetry suggest an 
adequate balance between systemic and pulmonary blood flow.  Judicious use of inotropic support is initiated if evidence 
of low cardiac output is detected. Diuretics may be necessary to help alleviate the increased volume load on the right ven-
tricle. The goal of respiratory management is to increase pulmonary vascular resistance and decrease systemic vascular 
resistance.  Infants with HLHS who are born with a severely restricted or no inter-atrial communication, a rare occurrence, 
have profound hypoxemia.  The severe restriction of blood flow across the atrial septum results in a life-threatening situati-
on and these patients, which present with severe cyanosis and hemodynamic instability, require urgent postnatal cardiac 
catheterization to relieve the septal obstruction and improve oxygenation. Special attention should be paid to the prevention 
of brain injury and poor neurodevelopmental outcome. 
Care for infants with HLHS is complex, and often multiple specialists are involved. Despite an increase in the number of 
newborns with complex congenital heart disease and a growing percentage of patients with single-ventricle physiology, it is 
possible to care for this particular group of patients and achieve acceptable mortality risks, even in centres with no pediatric 
cardiac surgery facilities, if good preoperative management protocols are followed. 
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Introduction
O tempora, o mores.  Too often, little 
interest is shown toward the intensely 
cyanotic and desperately ill newborn 
because the majority of causative 
lesions do not lend themselves to 
correction and infrequently to satis-
factory palliation, stated Hall and co-
workers in Circulation in 1965. (1) At 
that time the reported survival rates for 
newborns with structural heart disea-
se ranged from 31% to 37%.  It was 
only 15 years later that Izukava et al. 
reported the increasing survival rate in 
newborns with CHD (Congenital Heart 
Disease) at 70%, in the first month after 
surgery. (2) 
Pediatric care providers are repeated-
ly called upon to evaluate a cyano-
tic newborn in the labor and delivery 
room, as well as in the well baby nur-
sery. Causes of hypoxia and cyanosis 
in the term newborn can be found within 
all physiological systems and take the 
form of hundreds of specific diagnoses. 
Among them, congenital heart struc-
tural diseases account for the largest 
diagnostic category.   
There have been significant advances 
during the past years in the diagnosis 
and treatment of neonates with critical 
congenital heart disease, especially 
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in the field of pre- and post-operative 
intensive care. (3) 
Optimal preoperative care involves /1/ 
primary stabilization, airway manage-
ment and establishment of vascular 
access; /2/ complete noninvasive defi-
nition of structural defects; /3/ evaluati-
on and treatment of secondary organ 
dysfunction; /4/ cardiac catheteriza-
tion. 
Congenital heart diseases are complex 
and can be difficult to categorize or 
conceptualize. Rather than trying to 
determine the management for each 
individual anatomical defect, a physi-
ological approach can be taken. The 
basic issues that should be evaluated 
are /1/ the way in which the systemic 
venous return reaches the systemic 
arterial circulation; /2/ the characteri-
stics of the connection between the 
pulmonary and systemic circulation; /3/ 
whether the defects are amenable to a 
two-ventricle or single-ventricle repa-
ir; /4/whether pulmonary blood flow is 
increased or decreased; /5/ whether 
there is a volume load or pressure load 
on the ventricles;
Hypoplastic left heart syndrome (HLHS) 
is the ultimate challenge for the neona-
tal and/or pediatric intensivist. Despite 
the advances in the management of 
HLHS, due to the development of new 
surgical techniques, it remains the most 
retractable congenital heart disease 
with a high mortality rate. However, by 
carrying out appropriate preoperative 
management the preoperative condi-
tion can be stabilized in most cases, 
even in patients with heart failure on 
admission. (4) 
The term HLHS describes a spectrum 
of cardiac structural abnormalities cha-
racterized by marked hypoplasia of the 
left ventricle and ascending aorta. The 
aortic and mitral valves may be atretic, 
hypoplastic or stenotic. Unless a large 
patent ductus arteriosus (DA) supplies 
the systemic circulation, the syndro-
me is uniformly lethal in the immediate 
postpartal period.  Prenatal diagnosis, 
initial resuscitation and optimal pre-
operative management are key ele-
ments that allow the best opportunity 
for low mortality and normal neurode-
velopment in affected newborns. (5) 
Peri-operative mortality is a significant 
concern, and patients with HLHS are 
at risk preoperatively, intraoperatively, 
and especially postoperatively. 
Preoperative management 
A fundamental understanding of the role 
of pulmonary and systemic resistance 
in determining blood flow and adequate 
interpretation of systemic arterial and 
venous oxygen saturations (SaO2 and 
SVO2, respectively)
 are crucial to the 
optimal clinical management of infants 
with HLHS from the very beginning. (6) 
The neonate with HLHS has a very com-
plex cardiovascular physiology. The 
oxygenated blood returning through 
the pulmonary veins to the left atrium 
cannot flow into the left ventricle beca-
use of the dysfunctional mitral valve. 
Accordingly, it crosses the atrial sep-
tum through a septal defect and mix 
with the desaturated blood in the right 
atrium. The mixed blood leaving the 
right ventricle flows to the lungs via the 
pulmonary arteries and to the body 
via the open DA. Hence, fully open, 
unrestrictive, communications through 
the atrial septum and DA are the main 
conditions of survival for a newborn 
with HLHS.
Clinically, the syndrome typically pre-
sents within the first 24 to 48 hours of 
life, when the constriction of the DA cau-
ses a decrease in systemic blood flow, 
shock and eventually death. Infants 
with an absent or restrictive interatrial 
communication may present earlier.
Open the ductus
 Preoperatively the goal is to achieve 
adequate systemic oxygen delivery. 
Patency of the ductus arteriosus is criti-
cal for survival until surgery. Blood flow 
to the pulmonary and systemic circulati-
ons should be nearly balanced (goal 
p/ s ratio of 1).  The immediate
 therapy 
for all infants with HLHS is an intra-
venous infusion of prostaglandin E1 
(PGE1) in order to pharmacologically 
manipulate the DA and maintain ductal 
patency. A continuous infusion of the 
prostaglandin is initiated, preferably 
through a central catheter, at a rate of 
0.05 to 0.1 g/kg per minute.  However, 
numerous side effects are associated 
with PGE1 infusion such as respiratory 
depression, fever, lethargy, irritability, 
myoclonic jerks, flushing, edema, pylo-
ric stenosis, hyperostosis, necrotizing 
enetrocolitis, as well as structural remo-
deling of the DA and the pulmonary 
vessels, with a reported incidence of 
these complications ranging from 10 to 
40%. (7,8) In the future Sildenafil could 
be a reasonable alternative to PGE1 for 
maintaining DA patency, since it can 
also prevent and reverse DA closure 
through a mechanism that is distinct, 
and eventually safer, from the PGE1 
mechanism. (9) An audible murmur and 
adequate peripheral perfusion provide 
evidence of ductal patency; however, 
Doppler echocardiography is needed to 
confirm flow. Once the ductus is open, 
the rate of infusion may be reduced to 
decrease the risk for potential adverse 
effects. Unrestricted blood flow throu-
gh the ductus arteriosus is necessary 
for systemic perfusion.  Sometimes 
even a temporary discontinuation of the 
prostaglandin infusion is possible, with 
careful monitoring of blood pressure 
and urine volume as well as frequent 
echocardiographic examinations, in 
order to enable maintenance of balan-
ce between systemic and pulmonary 
blood flow. (4)
Balance the circulation
The p/ s ratio preoperatively
 is dic-
tated by the adequacy of the intera-
trial communication. An infant with a 
mildly restrictive interatrial communi-
cation may have balanced circulation 
and remain in a clinically stable con-
dition as long as the ductus arteriosus 
remains open. Oxygen saturations of 
75% to 85% by pulse oximetry suggest 
adequate balance between systemic 
and pulmonary blood flow.  Ventilatory 
support may be needed for apneic epi-
sodes or tenacious secretions, both 
common adverse effects of treatment 
with prostaglandin E1. Judicious use of 
inotropic support is initiated if evidence 
of low cardiac output is detected. Infusi-
on of dopamine at a rate of 3 to 5 g/kg 
per minute usually results in improved 
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ventricular function. High-dose inotro-
pic support should be used with cau-
tion because it can result in increased 
SVR (systemic vascular resistance) and 
cause a shift in the p/ s
 ratio to gre-
ater than 1. In our institution we do not 
recommend the use of dopamine as a 
“standard” since we consider it a “dirty” 
drug with a lot of potential unexpected 
effects. Diuretics may be necessary 
to help alleviate the increased volume 
load on the right ventricle. 
Infants with an unrestrictive inter-atri-
al communication may be in a stable 
condition initially, but signs of conge-
stive heart failure may develop as the 
PVR (pulmonary vascular resistance) 
decreases. When oxygen saturations 
are approximately 90%, systemic blood 
flow may be reduced, resulting in tissue 
hypoperfusion, metabolic acidosis, and 
a low cardiac output state.  In infants 
with high oxygen saturation and eviden-
ce of tissue hypoperfusion, controlled 
mechanical ventilation is often initiated 
to improve the p/ s ratio and syste-
mic cardiac output. 
Severe tricuspid regurgitation (TR) 
could be another issue that complicates 
the life of the intensivist dealing with a 
newborn with HLHS. Good preoperati-
ve management with mechanical venti-
lation in order to lower the degree of TR 
results in a better short-term prognosis 
of stage 1 Norwood operation. (4) 
The goal of respiratory management 
is to increase pulmonary vascular resi-
stance and decrease systemic vas-
cular resistance. The p/ s ratio can 
be manipulated by increasing PVR by 
increasing the PaCO2. PaCO2 can be 
increased by adding supplemental 
inspired carbon dioxide, a potent pul-
monary vasoconstrictor, to the ventila-
tor circuit. This approach for increasing 
PaCO2 is preferred over hypoventilati-
on, which may lead to atelectasis. PVR 
can also be increased by decreasing 
the concentration of inspired oxygen 
by adding supplemental nitrogen gas 
to attain a fraction of inspired oxygen of 
0.17 to 0.19. PVR can also be increased 
by maintaining the hematocrit at greater 
than 0.40, a state that optimizes oxy-
gen-carrying capacity and increases 
the viscosity of the blood. Although 
these medical management strategi-
es may provide temporary palliation, 
infants with marked pulmonary overcir-
culation and systemic hypoperfusion 
benefit from early surgical correction, 
because the methods to reverse this 
situation have limited effectiveness. 
Infants with HLHS who are born with a 
severely restricted or no inter-atrial com-
munication, a rare occurrence, have pro-
found hypoxemia. In fact, morbidity and 
mortality remain high in the subset of 
patients with an intact or very restrictive 
atrial septum. (10) The severe restriction 
of blood flow across the atrial septum 
results in a life-threatening situation and 
these patients, which present with severe 
cyanosis and hemodynamic instability, 
require urgent postnatal cardiac cathe-
terization to relieve the septal obstructi-
on and improve oxygenation. (11) Relief 
of the obstruction can be achieved by 
a balloon atrial septostomy or blade 
septostomy at the time of cardiac cathe-
terization or a surgical atrial septectomy. 
The tenuous condition of these infants 
makes each of these interventions high 
risk. The choice of intervention depends 
on the severity of the obstruction, the 
infant’s cardiac anatomy and physiolo-
gy, and the experience of the available 
medical and surgical team.  
Keep the brain in mind
Special attention should be paid to the 
prevention of brain injury to avoid poor 
neurodevelopmental outcome. Children 
with HLHS have an increased prevalen-
ce of central nervous system (CNS) 
abnormalities, which traditionally have 
been attributed to chronic cyanosis 
and multiple exposures to cardiopul-
monary bypass. (12) However, there is 
a theory, supported by identification of 
white matter injury in term neonates with 
HLHS before surgery, that the impaired 
antegrade aortic blood flow and con-
sequent reduced cerebral blood flow 
adversely impact the CNS development 
in such babies. (13) Unfortunately it 
seems to have a great impact on the 
overall success of treatment for chil-
dren with HLHS, in terms of a definitive 
satisfactory outcome. Presurgical brain 
injury is common even among children 
with the best prognostic characteristics 
who receive care in tertiary centers. 
Thus, the majority of surviving children 
who are born with hypoplastic left heart 
will not have normal psychomotor deve-
lopment at age one year and parents 
should be counseled accordingly. (14) 
Conclusion
Care for infants with HLHS is complex 
and often multiple specialists are invol-
ved. Certainly, the best way to manage 
a newborn with critical heart disease 
is to diagnose the defect prenatally in 
order to arrange delivery near experi-
enced pediatric cardiac surgery insti-
tutions. Nevertheless, despite an incre-
ase in the number of newborns with 
complex congenital heart disease and 
a growing percentage of patients with 
single-ventricle physiology, it is possi-
ble to care for this particular group of 
patients and achieve an acceptable 
mortality risk, even in centers with no 
pediatric cardiac surgery facilities, if 
good preoperative management proto-
cols are followed. (15) 
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